| Literature DB >> 36104983 |
Alberto F Fameli1, Jessie Edson1, Jeremiah E Banfield2, Christopher S Rosenberry2, W David Walter3.
Abstract
Chronic wasting disease (CWD) is a fatal encephalopathy affecting North American cervids. Certain alleles in a host's prion protein gene are responsible for reduced susceptibility to CWD. We assessed for the first time variability in the prion protein gene of elk (Cervus canadensis) present in Pennsylvania, United States of America, a reintroduced population for which CWD cases have never been reported. We sequenced the prion protein gene (PRNP) of 565 elk samples collected over 7 years (2014-2020) and found two polymorphic sites (codon 21 and codon 132). The allele associated with reduced susceptibility to CWD is present in the population, and there was no evidence of deviations from Hardy-Weinberg equilibrium in any of our sampling years (p-values between 0.14 and 1), consistent with the lack of selective pressure on the PRNP. The less susceptible genotypes were found in a frequency similar to the ones reported for elk populations in the states of Wyoming and South Dakota before CWD was detected. We calculated the proportion of less susceptible genotypes in each hunt zone in Pennsylvania as a proxy for their vulnerability to the establishment of CWD, and interpolated these results to obtain a surface representing expected proportion of the less susceptible genotypes across the area. Based on this analysis, hunt zones located in the southern part of our study area have a low proportion of less susceptible genotypes, which is discouraging for elk persistence in Pennsylvania given that these hunt zones are adjacent to the deer Disease Management Area 3, where CWD has been present since 2014.Entities:
Keywords: Chronic wasting disease; elk; genetic variability; prion protein gene; spatial variability
Mesh:
Substances:
Year: 2022 PMID: 36104983 PMCID: PMC9481152 DOI: 10.1080/19336896.2022.2117535
Source DB: PubMed Journal: Prion ISSN: 1933-6896 Impact factor: 2.547
Figure 1.a) Distribution of elk samples (circles) collected in Pennsylvania’s Elk Management Area (EMA, current delineation shown) between 2014 and 2020 (n = 565). Disease Management Area 3 (DMA3, cross-hatched) is adjacent to EMA, while Disease Management Area 6 (DMA6, hatched) is inside EMA. b) Distribution of elk samples (circles) as shown in Figure 2a, and hunt zone delineation used in the period 2018–2020, for which we estimated the proportions of less susceptible genotypes. These hunt zones are located within the Elk Management Area. Two hunt zones were created during our sampling period: zone 13 (incorporated in 2015) and zone 14 (incorporated in 2018).
Haplotypes inferred based on the two polymorphic sites found in our study of elk from the state of Pennsylvania, U.S.A., and those reported by Chafin et al. [47] for white-tailed deer. For comparison purposes, we only show their results for two polymorphic sites: one (nucleotide 60) in a position similar to the one we found and the other (nucleotide 286) linked to differential CWD-susceptibility in white-tailed deer (similar to nucleotide 394 in elk PRNP sequence).
| Elk | White-tailed deer | ||||
|---|---|---|---|---|---|
| Nucleotides 63/394 | N | % | Nucleotides 60/286 | % | |
| C/A | 1016 | 89.91 | C/G | 71.46 | |
| C/T | 1 | 0.09 | C/A | 17.24 | |
| T/T | 113 | 10 | T/G | 11.24 | |
| T/A | 0 | 0 | T/A | 0.07 | |
Frequencies of the different PRNP genotypes based on polymorphism at nucleotide 394 in our study, and those reported for other elk populations. N = number of individuals, % = percentage in our sample, JN% = percentage calculated from a sample of 55 individuals from Wyoming [11], BH% = percentage calculated from a sample of 42 individuals from South Dakota [11], WIND% = percentage calculated from a sample of 186 individuals from Wyoming [10], ABSA% = percentage calculated from a sample of 148 individuals from Wyoming [10], THRO% = percentage calculated from a sample of 199 individuals from North Dakota [10], PA% = percentage found in our dataset based on a bootstrapping procedure, adjusting sample size to match the ones obtained in previous studies for different populations.
| Pennsylvania | Other populations | ||||||
|---|---|---|---|---|---|---|---|
| | N | % | JN% | BH% | WIND% | ABSA% | THRO% |
| (PA%) | (PA%) | (PA%)* | (PA%) | (PA%)** | |||
| Met/Met | 456 | 80.71 | 80 | 83 | 69 | 74 | 93 |
| (80.79) | (80.77) | (80.69) | (80.71) | (80.88) | |||
| Met/Leu | 104 | 18.41 | 20 | 17 | 27 | 24 | 7 |
| (18.29) | (18.34) | (18.40) | (18.38) | (18.25) | |||
| Leu/Leu | 5 | 0.88 | 0 | 0 | 4 | 1 | 1 |
| (0.91) | (0.89) | (0.90) | (0.91) | (0.87) | |||
*p-value<0.05
**p-value<0.001
Figure 2.Distribution of less susceptible PRNP genotypes (Met/Leu and Leu/Leu) obtained from our sample of 565 elk, shown as: (a) presence of the 109 less susceptible genotypes using individual GPS coordinates, and (b) interpolation based on the proportion of Met/Leu individuals in each hunt zone, with circles representing Leu/Leu individuals. The interpolation combining both types of less susceptible genotypes showed the same pattern.